迪芬胺:对其临床应用和潜在不良影响概况的审查
Wajahat Nazir Khan1, Joseph D Tobias2
1Department of Anesthesiology & Pain Medicine, Nationwide Children's Hospital, Columbus, OH (WNK).
双胺,一种抗组胺,有效治疗过敏,但可能导致不良影响. 快速或过量的剂量,特别是静脉注射,会增加毒性风险.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床毒理学 临床毒理学
背景情况:
- 迪芬胺是一种广泛使用的第一代抗胺剂,用于过敏症.
- 它可以在非处方药店购买,但存在副作用和毒性的风险.
研究的目的:
- 审查史,生理效应,和diphenhydramine的临床应用.
- 检查报告的不良影响,包括危及生命的事件.
- 讨论减轻二胺相关毒性的策略.
主要方法:
- 对diphenhydramine的发展和不良事件报告的文献综述.
- 分析生理效应和临床用例.
- 对毒性管理策略的讨论.
主要成果:
- 迪芬胺是有效的过敏反应,如过敏反应和疹.
- 快速静脉注射和过量剂量与显著的毒性有关.
- 报告了临床上显著的不良事件,有些危及生命.
结论:
- 虽然对过敏有好处,但狄芬胺需要小心地使用,以避免毒性.
- 了解其风险对于安全的临床实践至关重要.
- 现有策略可以限制不良生理影响,并管理过量情况.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Cholinergic Antagonists: Pharmacokinetics
